Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery

International Journal of Obesity

Volumn 39, Issue 5, 2015, Pages 798-805

  Hao, Z ^a   Munzberg H ^a   Rezai Zadeh, K ^a   Keenan, M ^b   Coulon, D ^b   Lu, H ^c   Berthoud, H R ^a   Ye, J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN;

ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY TEMPERATURE; BODY WEIGHT; CALORIC RESTRICTION; CALORIE; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LEPTIN DEFICIENCY; LIPID DIET; LUNG GAS EXCHANGE; MALE; MOUSE; NONHUMAN; OB/OB MOUSE; OXYGEN CONSUMPTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; TREATMENT RESPONSE; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DEFICIENCY; DISEASE MODEL; GASTRIC BYPASS SURGERY; METABOLISM; MOUSE MUTANT; OBESITY; PROCEDURES; REPRODUCIBILITY;

MUS;

ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GASTRIC BYPASS; INSULIN RESISTANCE; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; REPRODUCIBILITY OF RESULTS; WEIGHT GAIN; WEIGHT LOSS;

EID: 84928929535     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.189     Document Type: Article

References (35)

1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
2. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014; 370: 2002-2013.
3. Coll AP, Farooqi IS, O'Rahilly S. The hormonal control of food Intake. Cell 2007; 129: 251-262.
4. Stefater MA, Wilson-Perez HE, Chambers AP, Sandoval DA, Seeley RJ. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev 2012; 33: 595-622.
5. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240: 236-242.
6. Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709-1716.
7. Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 2006; 14: 1553-1561.
8. Chandarana K, Gelegen C, Karra E, Choudhury AI, Drew ME, Fauveau V et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes 2011; 60: 810-818.
9. Cummings D. E, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608-2615.
10. Ye J, Hao Z, Mumphrey MB, Townsend RL, Patterson LM, Stylopoulos N et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol 2014; 306: R352-R362.
11. Mokadem M, Zechner JF, Margolskee RF, Drucker DJ, Aguirre V. Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. Mol Metab 2013; 3: 191-201.
12. Chambers AP, Jessen L, Ryan KK, Sisley S, Wilson-Perez HE, Stefater MA et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 2011; 141: 950-958.
13. Abegg K, Schiesser M, Lutz TA, Bueter M. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass. Physiol Behav 2013; 121: 70-78.
14. Wilson-Perez HE, Chambers AP, Sandoval DA, Stefater MA, Woods SC, Benoit SC et al. The effect of vertical sleeve gastrectomy on food choice in rats. Int J Obes (Lond) 2013; 37: 288-295.
15. Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010; 138: 2426-2436 2436 e1-3.
16. Grayson BE, Schneider KM, Woods SC, Seeley RJ. Improved rodent maternal metabolism but reduced intrauterine growth after vertical sleeve gastrectomy. Science Transl Med 2013; 5: 199ra112.
17. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998; 1: 619-625.
18. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010; 151: 1588-1597.
19. Xu Y, Ohinata K, Meguid MM, Marx W, Tada T, Chen C et al. Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res 2002; 107: 56-63.
20. Meirelles K, Ahmed T, Culnan DM, Lynch CJ, Lang C. H, Cooney RN. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg 2009; 249: 277-285.
21. Hao Z, Zhao Z, Berthoud H-R, Ye J. Development and erification of a mouse model for Roux-en-Y gastric bypass surgery with a small gastric pouch. PLoS One 2013; 8: e52922.
22. Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B, Mynatt R et al. Uncoupling of inflammation and insulin resistance by NF-kB in transgenic mice through induction of energy expenditure. J Biol Chem 2010; 285: 4637-4644.
23. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004; 304: 108-110.
24. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996; 14: 95-97.
25. Harris RB, Zhou J, Redmann SM Jr, Smagin GN, Smith SR, Rodgers E et al. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 1998; 139: 8-19.
26. Isbell JM, Tamboli RA, Hansen EN, Saliba J, Dunn JP, Phillips SE et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010; 33: 1438-1442.
27. Jackness C, Karmally W, Febres G, Conwell IM, Ahmed L, Bessler M et al. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell function in type 2 diabetic patients. Diabetes 2013; 62: 3027-3032.
28. Lingvay I, Guth E, Islam A, Livingston E. Rapid improvement of diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care 2013; 36: 2741-2747.
29. Buch TR, Heling D, Damm E, Gudermann T, Breit A. Pertussis toxin-sensitive signaling of melanocortin-4 receptors in hypothalamic GT1-7 cells defines agouti-related protein as a biased agonist. J Biol Chem 2009; 284: 26411-26420.
30. Farooqi S, O'Rahilly S. Genetics of obesity in humans. Endocr Rev 2006; 27: 710-718.
31. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095.
32. Hatoum IJ, Stylopoulos N, Vanhoose AM, Boyd KL, Yin DP, Ellacott KL et al. Melanocortin-4 receptor signaling Is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2012; 97: E1023-E1031.
33. Zechner JF, Mirshahi UL, Satapati S, Berglund ED, Rossi J, Scott MM et al. Weightindependent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology 2013; 144: 580-590 e7.
34. Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014; 509: 183-188.
35. Saeidi N, Meoli L, Nestoridi E, Gupta NK, Kvas S, Kucharczyk J et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 2013; 341: 406-410.